Cryptococcosis classification

Cryptococcosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cryptococcosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cryptococcosis classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cryptococcosis classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cryptococcosis classification
CDC on Cryptococcosis classification
Cryptococcosis classification in the news
Blogs on Cryptococcosis classification
Directions to Hospitals Treating Cryptococcosis
Risk calculators and risk factors for Cryptococcosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian M.D.; Yazan Daaboul, M.D.

Overview

Cryptococcosis may be classified based on the site of infection i.e. the clinical syndrome into pulmonary, CNS, or disseminated cryptococcosis. Another approach to the classification involves the species or variety of the cryptococcus causative organism and includes Cryptococcus neoformans, Cryptococcus gattii, and other rares species.

Classification

Cryptococcosis may be classified based on the site of infection i.e. the clinical syndrome, or the species or variety of the cryptococcus causative organism.

Site of Infection

• Pulmonary Cryptococcosis

• The most common clinical syndrome associated with Cryptococcus, but may be asymptomatic.
• Related to the mode of transmission via aerosolized basidiospores.
• Extra-pulmonary infections are thought to be secondary to a primary pulmonary infection even in cases where the latter is not evident.

• Central Nervous System (CNS) Cryptococcosis

• Classically seen in patients with AIDS and low CD4 counts (below 100).
• Secondary to dissemination of inhaled spores in patients who are severely immunocompromised.
• Cryptococcosis is one of the leading causes of meningitis in adults worldwide.

• Disseminated Cryptococcosis

• Most often involves the skin, soft tissue, and the medulla of the bone in addition to the lungs and CNS.
• Also associated with a severely immunocompromised status.

Causative Species or Variety

• Cryptococcus neoformans

• The most common cryptococcal species associated with human disease.
• Variety includes:
• Cryptococcus neoformans v. neoformans (serotype D)

• The major causative agent of cryptococcosis in Europe.

• Cryptococcus neoformans v. grubii (serotype A)

• The major causative agent of cryptococcosis in Asia and the US.

• Cryptococcus gattii

• Previously a variant of C. neoformans, currently classified as a separate species.
• Emerging as a common fungal pathogen in the Pacific Northwest of the USA.

• Cryptococcus uniguttulatus

• Very rare. Associated with ventriculitis.
• First isolated from a human nail.

• Cryptococcus laurentii

• Rare. Associated with fungemia, lung abscesses, and meningitis

• Cryptococcus albidus

• Very rare. Associated with ocular infections, and meningitis.

• Although other species of cryptococci exist, they are not known to be infectious to humans.